{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:25:25Z","timestamp":1789979125052,"version":"4.0.1"},"reference-count":28,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T00:00:00Z","timestamp":1450742400000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      To compare the effect of renin\u2010angiotensin\u2010aldosterone system (\n                      <jats:styled-content style=\"fixed-case\">RAAS<\/jats:styled-content>\n                      ) blockers with that of other antihypertensive agents on outcomes in a cohort of elderly veterans with incident chronic kidney disease (\n                      <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n                      ) without diabetes mellitus or proteinuria.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>\n                      Veterans Affairs (\n                      <jats:styled-content style=\"fixed-case\">VA<\/jats:styled-content>\n                      ) Upstate New York Healthcare System.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>\n                      All participants were seen in primary care clinic in Veterans Integrated Service Network 2, which comprises five\n                      <jats:styled-content style=\"fixed-case\">VA<\/jats:styled-content>\n                      medical centers and 29 community\u2010based outpatient clinics, from April 2001 to April 2008. Veterans with incident\n                      <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n                      who were taking antihypertensive medications and did not have proteinuria or diabetes mellitus on the date of onset of\n                      <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n                      were selected from this population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements<\/jats:title>\n                    <jats:p>\n                      The outcome variables studied were progression of kidney disease (doubling of serum creatinine level or Stage 5\n                      <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n                      (estimated glomerular filtration rate &lt;15\u00a0mL\/min per 1.73\u00a0m\n                      <jats:sup>2<\/jats:sup>\n                      )), all\u2010cause mortality, and combined outcome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Analysis included 2,474 participants, 47.9% of whom were taking\n                      <jats:styled-content style=\"fixed-case\">RAAS<\/jats:styled-content>\n                      blockers at baseline and the rest other antihypertensives. Time\u2010varying Cox proportional hazards analyses did not reveal a statistically significant difference in primary combined outcome in participants taking\n                      <jats:styled-content style=\"fixed-case\">RAAS<\/jats:styled-content>\n                      blockers and those taking other antihypertensives (hazard ratio\u00a0=\u00a01.09, 95% confidence interval\u00a0=\u00a00.93\u20131.27). There was also no significant effect on individual outcomes (death or progression of kidney disease).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Use of\n                      <jats:styled-content style=\"fixed-case\">RAAS<\/jats:styled-content>\n                      blockers was not associated with less hazard of combined and individual outcomes (doubling of serum creatinine, Stage 5\n                      <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n                      , death) in elderly veterans with incident\n                      <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n                      without diabetes mellitus or proteinuria.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jgs.13842","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T06:39:07Z","timestamp":1450766347000},"page":"2478-2484","source":"Crossref","is-referenced-by-count":6,"title":["Renin\u2010Angiotensin\u2010Aldosterone System Blockers in Elderly Adults with Chronic Kidney Disease without Diabetes Mellitus or Proteinuria"],"prefix":"10.1111","volume":"63","author":[{"given":"Pradeep","family":"Arora","sequence":"first","affiliation":[{"name":"Department of Medicine University at Buffalo Buffalo New York"},{"name":"Department of Biostatistics University at Buffalo Buffalo New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Golzy","sequence":"additional","affiliation":[{"name":"Division of Nephrology Veterans Affairs Medical Center Buffalo New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilang","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Medicine Virginia Commonwealth University Richmond Virginia"},{"name":"Division of Nephrology Veterans Affairs Medical Center Richmond Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Quigg","sequence":"additional","affiliation":[{"name":"Department of Medicine University at Buffalo Buffalo New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolph L.","family":"Carter","sequence":"additional","affiliation":[{"name":"Division of Nephrology Veterans Affairs Medical Center Buffalo New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Lohr","sequence":"additional","affiliation":[{"name":"Department of Medicine University at Buffalo Buffalo New York"},{"name":"Department of Biostatistics University at Buffalo Buffalo New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,12,22]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End\u2010Stage Renal Disease in the United States.Bethesda MD:National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases 2012."},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2003.50007"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02490213"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-10-200905190-00010"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-2-200107170-00007"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2011.180"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-1-200801010-00190"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011303"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011161"},{"key":"e_1_2_6_11_1","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.73"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-11-201312030-00009"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311113292004"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)11445-8"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.19.2421"},{"key":"e_1_2_6_18_1","first-page":"CD007751","article-title":"Angiotensin\u2010converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non\u2010diabetic chronic kidney disease","volume":"10","author":"Sharma P","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.8.936"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.12700"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.050"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041031"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.4.421"},{"key":"e_1_2_6_24_1","volume-title":"Kidney Week","author":"Nainani N","year":"2011"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-006-0046-x"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.09.035"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078465"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.332"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.514"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjgs.13842","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjgs.13842","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgs.13842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T14:43:25Z","timestamp":1762181005000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/jgs.13842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1111\/jgs.13842"],"URL":"https:\/\/doi.org\/10.1111\/jgs.13842","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}